Parapsoriasis

Published on 19/03/2015 by admin

Filed under Dermatology

Last modified 19/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1804 times

Parapsoriasis

Alex Milligan, Rosie Davis and Graham A. Johnston

Evidence Levels:  A Double-blind study  B Clinical trial ≥ 20 subjects  C Clinical trial < 20 subjects  D Series ≥ 5 subjects  E Anecdotal case reports

image

The diagnosis parapsoriasis, even as an umbrella term, continues to cause diagnostic difficulties and there is still debate as to whether the variants described in this chapter are in fact precursors of cutaneous T-cell lymphoma. This chapter covers the entities small plaque parapsoriasis (SPP: chronic superficial scaly dermatitis; persistent superficial dermatitis; digitate dermatosis; xanthoerythroderma perstans) and large plaque parapsoriasis (LPP: parakeratosis variegata; retiform parapsoriasis; atrophic parapsoriasis; poikilodermatous parapsoriasis). Confusingly, the term parapsoriasis en plaque has been used for either SPP or LPP.

Other conditions sometimes grouped under the banner of parapsoriasis are pityriasis lichenoides et varioliformis acuta, pityriasis lichenoides chronica, and lymphomatoid papulosis, all of which are the subjects of separate chapters.

Management strategy

The diagnosis of parapsoriasis is made on clinical grounds, with histology supporting the clinical impression, especially when early cutaneous T-cell lymphoma is in the differential diagnosis. Patches of LPP are larger than 5 cm in diameter, and often 10 cm or larger, distinguishing them from SPP, which is characterized by lesions smaller than 5 cm.

If malignancy is considered in the differential diagnosis, T-cell receptor gene rearrangement studies are more likely to demonstrate monoclonality in cutaneous T-cell lymphoma, though monoclonality is not entirely sensitive or specific for the latter. Repeat studies may be warranted if progression to cutaneous T-cell lymphoma is suspected.

Although some advocate non-aggressive therapies, e.g., topical corticosteroids, for parapsoriasis, the potential for progression to cutaneous lymphoma in patients with LPP justifies the use of psoralen with UVA (PUVA). Sunlight, broadband UVB, and narrowband UVB have been used successfully as well, particularly for SPP.

Specific investigations

Immunohistochemistry cannot differentiate between the two forms.